Glaukos Corporation
NYSE: GKOS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Thomas William Burns
- Employees
- 995
- Headquarters
- Aliso Viejo, United States
- IPO year
- 2015
- Market cap
- $7.9B
- Website
- https://www.glaukos.com
Loading GKOS…
Loading profile data…Frequently asked questions about GKOS
What does Glaukos Corporation (GKOS) do?
Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueo...
Where does GKOS trade?
Glaukos Corporation (GKOS) trades on the New York Stock Exchange.
What sector is GKOS in?
Glaukos Corporation (GKOS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Glaukos Corporation?
Thomas William Burns is the chief executive officer of Glaukos Corporation (GKOS).
Where is Glaukos Corporation headquartered?
Glaukos Corporation is headquartered in United States.
Does GKOS pay a dividend?
Glaukos Corporation (GKOS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GKOS go public?
Glaukos Corporation (GKOS) completed its initial public offering in 2015.